Inventors list |
Agents list |
Assignees list |
List by place |
Classification tree browser |
Top 100 Inventors |
Top 100 Agents |
Top 100 Assignees |
GLOBAL PATENT GROUP - APX;Ms. LaVern Hall
ST. LOUIS, MO US
1. 20090176792 SUBSTITUTED DIBENZHYDRYLPIPERAZINES - new dibenzhydrylpiperazine modulators of histamine receptors pharmaceutical compositions thereof 07-09-20092. 20090068168 SUBSTITUTED AMINO ALCOHOLS - Disclosed herein are substituted amino alcohol anti-mycobacterial agents and/or chelation therapy agents of Formula I 03-12-2009
3. 20090028873 SUBSTITUTED CYCLOHEXANOLS - Disclosed herein are substituted cyclohexanol opioid receptor modulators and/or neurotransmitter reuptake modulators of 01-29-2009
4. 20090023765 SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY 01-22-2009
5. 20090022706 SUBSTITUTED CYCLOHEXENES - Disclosed herein are substituted cyclohexene TLR4 signaling pathway modulators of Formula I process of preparation thereof 01-22-2009
6. 20090018207 SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY 01-15-2009
7. 20090005431 SUBSTITUTED PYRROLIDINES - Disclosed herein are substituted pyrrolidine-based muscarinic receptor modulators of Formula I process of preparation thereof 01-01-2009
8. 20090005309 SUBSTITUTED PIPERIDINES - Disclosed herein are substituted piperidine-based muscarinic receptor modulators of Formula I process of preparation thereof 01-01-2009
9. 20080319026 SUBSTITUTED N-ARYL PYRIDINONES - Disclosed herein are substituted N-Aryl pyridinone fibrotic inhibitors and/or collagen infiltration modulators of 12-25-2008
10. 20080312247 SUBSTITUTED PIPERAZINES - Disclosed herein are substituted piperazine late Na 12-18-2008
11. 20080300316 SUBSTITUTED PHENETHYLAMINES - Disclosed herein are substituted phenethylamine alpha adrenergic receptor modulators of Formula I 12-04-2008
12. 20080280991 SUBSTITUTED NAPHTHALENES - Disclosed herein are substituted naphthalene-based melatonin receptor modulators and/or 5-HT receptor modulators of Formula I 11-13-2008
13. 20080280886 SUBSTITUTED UREAS - Disclosed herein are urea-based 5-HT receptor modulators pharmaceutically acceptable salts and prodrugs thereof 11-13-2008
14. 20080268071 SUBSTITUTED CYCLOHEXANONES - Disclosed herein are substituted cyclohexanone-based NMDA receptor modulators of Formula I process of preparation thereof 10-30-2008
15. 20080262086 SUBSTITUTED ANTHRANILIC ACIDS - Disclosed herein are substituted anthranilic acids pharmaceutically acceptable salts and prodrugs thereof 10-23-2008
16. 20080255200 SUBSTITUTED BENZIMIDAZOLES - Disclosed herein are substituted benzimidazole-based proton pump modulators of Formula I processes of preparation thereof 10-16-2008
17. 20080255036 SUBSTITUTED THIOPHENES - Disclosed herein are substituted pyrimidine-based endothelin modulators of Formula I processes of preparation thereof 10-16-2008
18. 20080248093 pH sensitive prodrugs of 2,6-diisopropylphenol 10-09-2008
19. 20080242687 SUBSTITUTED PYRIMIDINES - Disclosed herein are substituted pyrimidine-based endothelin modulators of Formula I processes of preparation thereof 10-02-2008
20. 20080241289 PREPARATION AND UTILITY OF NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS 10-02-2008
21. 20080234257 SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY 09-25-2008
22. 20080234229 Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders 09-25-2008
23. 20080221069 Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders 09-11-2008